novartis - dofaq.co
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
PeptiDream Expands Peptide Discovery Collaboration With Novartis
Contract Pharma - 30 Apr 2024
PeptiDream Expands Peptide Discovery Collaboration With Novartis ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership
BioSpace - 30 Apr 2024
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership ...
Stock Watch: Novartis And The Changing Face Of Big Pharma
Scrip - 30 Apr 2024
Stock Watch: Novartis And The Changing Face Of Big Pharma ...
From black holes to AI driven drug discovery – collaboration wins the day
Novartis - 29 Apr 2024
From black holes to AI driven drug discovery – collaboration wins the day ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
FiercePharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
NICE recommends new Novartis treatment for brain tumours
Pf Media - 25 Apr 2024
NICE recommends new Novartis treatment for brain tumours ...
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ...
Medicines for Malaria Venture - 24 Apr 2024
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ... ...
Novartis: CEO needs to convince over long-term prospects
Financial Times - 28 Nov 2023
Novartis: CEO needs to convince over long-term prospects ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
FiercePharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Novartis raises guidance after beating Q1 expectations
Reuters - 23 Apr 2024
Novartis raises guidance after beating Q1 expectations ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Animal Research
Novartis - 31 Jan 2024
Animal Research ...
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs
FiercePharma - 23 Apr 2024
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs ...